When is it Appropriate to Lower Low Density Lipoprotein-Cholesterol Levels to <30 mg/dL?

Nathan D. Wong; Raman Puri; Vimal Mehta; P. Barton Duell

doi:10.1016/j.amjcard.2021.06.041

When is it Appropriate to Lower Low Density Lipoprotein-Cholesterol Levels to <30 mg/dL?

Nathan D. Wong, Raman Puri, Vimal Mehta, P. Barton Duell

Knight Cardiovascular Institute

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	142-144
Number of pages	3
Journal	American Journal of Cardiology
Volume	157
DOIs	https://doi.org/10.1016/j.amjcard.2021.06.041
State	Published - Oct 15 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2021.06.041

Cite this

@article{1816aca69521463a924cd91d952b7bb2,

title = "When is it Appropriate to Lower Low Density Lipoprotein-Cholesterol Levels to <30 mg/dL?",

author = "Wong, {Nathan D.} and Raman Puri and Vimal Mehta and Duell, {P. Barton}",

note = "Funding Information: Dr. Wong has received research support through his institution from Novartis and Esperion and is also a consultant for Novartis. Dr Duell as served as an advisor and/or has received institutional grants from: Akcea, Amryt, Esperion, Regeneron, Regenxbio, and Retrophin/Travere. Dr. Mehta has received institutional research grants from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Torrent. Dr Puri does not report any potential conflicts of interest.",

year = "2021",

month = oct,

day = "15",

doi = "10.1016/j.amjcard.2021.06.041",

language = "English (US)",

volume = "157",

pages = "142--144",

journal = "American Journal of Cardiology",